Particle Therapy Spot Trajectory Optimization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current radiation therapy techniques face challenges in effectively sparing healthy tissue, particularly when delivering ultra-high dose rates, as they often result in degraded treatment plan quality and inadequate protection of healthy tissues during particle therapy.

Innovation Solution

The systems and techniques optimize temporal and spatial dose heterogeneity by optimizing spot trajectories and weights, using existing devices, to minimize healthy tissue exposure while maintaining treatment plan quality, incorporating methods like FLASH and GRID radiotherapy to achieve maximum tissue sparing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If conventional radiation therapy techniques are used to deliver ultra-high dose rates, then tumor control is achieved, but healthy tissue is inadequately protected and normal tissue toxicities increase

Engineering Contradiction:
Improvenormal tissue toxicitiesVSAvoidtreatment plan quality
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The treatment beam is segmented into multiple spot trajectories that are delivered sequentially. Each spot trajectory targets a specific region of the tumor, allowing the system to distribute the ultra-high dose rate treatment across multiple discrete paths rather than a single continuous beam, thereby sparing healthy tissues between the spots.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies different dose rates and trajectory patterns to different spatial regions. Ultra-high dose rates are concentrated within the tumor volume through optimized spot trajectories, while healthy tissues receive lower or fractionated doses. This local differentiation of dose quality achieves tumor control while protecting surrounding healthy structures.

Inventive Principle:
Principle #3Local quality

2Productivity

If ultra-high dose rates are delivered to the entire target, then treatment time is reduced, but healthy tissue exposure increases and treatment plan quality degrades

Engineering Contradiction:
Improvetreatment efficiencyVSAvoidhealthy tissue exposure
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent employs dynamic spot trajectory optimization where the beam path, spot positions, and weights are continuously adjusted during treatment. This dynamic approach allows the system to deliver ultra-high dose rates efficiently to tumor regions while adaptively avoiding or minimizing exposure to healthy tissues, maintaining both treatment efficiency and tissue sparing.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The treatment delivers radiation in periodic pulses through sequential spot trajectories rather than continuous exposure. Each spot trajectory represents a periodic action that concentrates dose delivery in discrete temporal and spatial intervals, allowing healthy tissues to receive reduced cumulative exposure while maintaining high dose rates within the tumor during active treatment periods.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS20240399170A1Particle therapy using temporo-spatial dose heterogeneities
Publication Date: 2024.12.05 ELEKTA AB
  • US20240399170A1 patent drawing
  • US20240399170A1 patent drawing
  • US20240399170A1 patent drawing

AI summary

Systems and methods may be used for protecting healthy tissue in particle therapy. For example, a method may include defining a particle arc range for a radiotherapy treatment of a patient. The method may include generating a spot selection for an arc sequence, including a trajectory for delivering the radiotherapy treatment, for example, based on a temporal dose heterogeneity parameter or a spatial dose heterogeneity parameter. The method may include optimizing fluence of the arc sequence for the radiotherapy treatment, for example, based on an applied temporal dose heterogeneity specific cost function or an applied spatial dose heterogeneity specific cost function.